DNA Topoisomerase I Gene Copy Number and mRNA Expression Assessed as Predictive Biomarkers for Adjuvant Irinotecan in Stage II/III Colon Cancer

导出原文传递

翻译打印收藏纠错

作者： Nygard, Sune Boris ^[1] ; Vainer, Ben ^[2] ; Nielsen, Signe Lykke ^[3] ; Bosman, Fred ^[4] ; Tejpar, Sabine ^[5] ; Roth, Arnaud ^[6] ; Delorenzi, Mauro ^[7] ; Brunner, Nils ; Budinska, Eva

作者单位： Masaryk Univ, Inst Biostat & Anal, Brno, Czech Republic ^[1] Copenhagen Univ Hosp, Dept Pathol, Rigshosp, Copenhagen, Denmark ^[2] Univ Copenhagen, Fac Hlth & Med Sci, DK-2100 Copenhagen, Denmark ^[3] SIB Swiss Inst Bioinformat, Bioinformat Core Facil, Lausanne, Switzerland ^[4] Univ Lausanne, Univ Inst Pathol, Lausanne, Switzerland ^[5] Univ Hosp Gasthuisberg, Digest Oncol Unit, Leuven, Belgium ^[6] Univ Hosp Geneva, Oncosurg Unit, Geneva, Switzerland ^[7]

发布时间 2017-04-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Clinical cancer research

2016年22卷7期

1621-1631页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

DNA Topoisomerase I Gene Copy Number and mRNA Expression Assessed as Predictive Biomarkers for Adjuvant Irinotecan in Stage II/III Colon Cancer

Clinical cancer research

相似文献

Clinical cancer research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

DNA Topoisomerase I Gene Copy Number and mRNA Expression Assessed as Predictive Biomarkers for Adjuvant Irinotecan in Stage II/III Colon Cancer

Clinical cancer research

相似文献

Clinical cancer research

相关期刊

检索历史清除